|
시장보고서
상품코드
1935152
천식 치료제 시장 : 약제 클래스별, 투여 경로별, 유통경로별, 지역별Asthma Therapeutics Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
천식 치료제 시장은 2026년에 204억 4,000만 달러로 추정되며, 2033년까지 233억 달러에 이를 전망입니다. 2026-2033년 연평균 복합 성장률(CAGR)은 1.9%로 예측되고 있습니다.
| 보고서의 내용 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 204억 4,000만 달러 |
| 과거 데이터 대상 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 1.90% | 2033년 예측 : | 233억 달러 |
천식은 폐의 기도에 염증과 협착을 일으키는 장기적인 염증성 질환입니다. 기도 내벽의 부종과 염증, 기침, 호흡곤란, 가슴 압박감 등 다양한 증상이 특징입니다. 천식은 알레르기성 천식, 비알레르기성 천식, 성인 발병 천식, 운동 유발성 천식(신체 활동 시 발생), 야간 천식, 직업성 천식 등 여러 가지 유형으로 나뉩니다. 야간 천식은 야간형 천식이라고도 합니다. 매우 심각한 유형의 천식이기 때문에 적절한 진단과 치료가 필요합니다.
시장 역학
주요 기업들의 분무기 신제품 출시 증가는 세계 천식 치료제 시장의 성장을 가속할 것으로 예측됩니다. 예를 들어, 2018년 10월, Koninklijke Philips N.V.는 북미에서 새로운 메쉬 분무기 'InnoSpire Go'의 출시를 발표했습니다. 천식을 포함한 호흡기 질환 치료에 사용됩니다. 휴대용 휴대용 분무기 시스템으로 단시간에 치료가 가능한 휴대용 분무기 시스템입니다. 단 4분 만에 약물을 투여합니다. InnoSpire Go는 성인과 어린이 모두를 위해 설계되었습니다.
그러나 제품 회수는 천식 치료제 시장 성장의 주요 억제요인으로 시장 성장을 저해할 것으로 예측됩니다. 예를 들어, 2018년 8월 미국 식품의약국(FDA)은 캠버 파마슈티컬스(Camber Pharmaceuticals)의 몬테루카스트 나트륨 정제에 대해 제품 회수 경보를 발령했습니다. 이 정제는 몬테루카스트나트륨정 병에 잘못된 의약품(로사르탄칼륨정)이 함유되어 회수되었습니다.
본 조사의 주요 특징
- 이 보고서는 2025년을 기준 연도로 하여 예측 기간(2026-2033년) 동안 전 세계 천식 치료제 시장 규모(10억 달러)와 연평균 성장률(CAGR)에 대한 상세한 분석을 제공합니다.
- 본 보고서에서는 다양한 부문의 잠재적 수익기회를 확인하고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명합니다.
- 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 또는 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략에 대한 중요한 정보도 제공합니다.
- 이 보고서는 기업 개요, 재무 성과, 제품 포트폴리오, 지리적 확장, 유통 전략, 주요 개발 및 전략과 같은 매개 변수를 기반으로 세계 천식 치료제 시장의 주요 기업 프로파일을 제공합니다.
- 이 보고서는 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 정부 정책, 기술 업그레이드, 시장 확대, 마케팅 전략과 관련하여 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
- 이 세계 천식 치료제 시장 보고서는 투자자, 제품 제조업체, 유통업체, 공급업체, 연구 및 컨설팅 회사, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자에게 유용한 정보를 제공합니다.
목차
제1장 조사 목적과 가정
제2장 시장 개요
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 천식 치료제 시장 : 약제 클래스별, 2026-2033년
제5장 세계의 천식 치료제 시장 : 투여 경로별, 2026-2033년
제6장 세계의 천식 치료제 시장 : 유통 채널별, 2026-2033년
제7장 세계의 천식 치료제 시장 : 지역별, 2026-2033년
제8장 경쟁 구도
제9장 섹션
LSH 26.03.09Asthma Therapeutics Market is estimated to be valued at USD 20.44 Bn in 2026 and is expected to reach USD 23.30 Bn by 2033, growing at a compound annual growth rate (CAGR) of 1.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 20.44 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 1.90% | 2033 Value Projection: | USD 23.30 Bn |
Asthma is a long-term inflammatory disease that causes inflammation and narrowing of the airways in the lung. It is characterized by various symptoms such as swelling or inflammation in the airways linings, coughing, shortness of breath, and tightness of chest. Asthma is classified into many different types including allergic asthma, non-allergic asthma, adult onset asthma, exercised induced asthma (that occurs with physical exertion), nocturnal asthma, and occupational asthma. Nocturnal is also known as the nighttime asthma. It is very serious type of asthma therefore, it needs a proper diagnosis and treatment.
Market Dynamics
Increasing launches of nebulizer by key players is expected to propel global asthma therapeutics market growth. For instance, in October 2018, Koninklijke Philips N.V. announced launch of its new mesh nebulizer, InnoSpire Go, in North America. This is used for the treatment of respiratory diseases including asthma. It is portable, hand-held nebulizer system, which is short time treatment. It delivers the medicine in just four minutes. InnoSpire Go designed for both adults and children.
However, product recall is major restraining factor for asthma therapeutics market growth, which is expected to hamper the market growth. For instance, in August 2018, Camber Pharmaceuticals were issued product recall alert from U.S. Food and Drug Administration for its Montelukast Sodium Tablets. These tablets are recalled because Montelukast Sodium Tablet bottles contain wrong medicine (Losartan Potassium Tablet).
Key features of the study
- This report provides in-depth analysis of the global asthma therapeutics market size (USD Bn), and compound annual growth rate (CAGR (%)) for the forecast period: 2026 - 2033, considering 2025, as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global asthma therapeutics market based on the following parameters-company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include, GlaxoSmithKline Plc., Philips Healthcare, AstraZeneca Plc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Sanofi-Aventis SA, CareFusion Corporation, Sunovion Pharmaceuticals, Inc. Merck & Co., Inc., and Roche Diagnostics.
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global asthma therapeutics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for global asthma therapeutics market, research and consulting firms, new entrants, and financial analysts
Market Segmentation
- Drug Class Insights (Revenue, USD Bn, 2026 - 2033)
- Corticosteroids
- Beta2-Agonists (Long-Acting and Short-Acting)
- Leukotriene Inhibitors
- Long-Acting Muscarinic Antagonists (LAMA)
- Interleukin Antagonists
- Anti-Immunoglobulin E (IgE) Agents
- Combination Products
- Others
- Route of Administration Insights (Revenue, USD Bn, 2026 - 2033)
- Oral, Inhalation
- Injection
- Distribution Channel Insights (Revenue, USD Bn, 2026 - 2033)
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- GlaxoSmithKline Plc.
- Philips Healthcare
- AstraZeneca Plc.
- Teva Pharmaceutical Industries Ltd.
- Boehringer Ingelheim GmbH,
- Sanofi-Aventis SA
- CareFusion Corporation
- Sunovion Pharmaceuticals, Inc.
- Merck & Co., Inc.
- Roche Diagnostics
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Technology Advancements
- Epidemiology
- Product Recalls
- Government Initiatives
- Historical Overview
- Merger and Acquisition
- Regulatory and Reimbursement Scenario
- PORTER'S Five Forces
- PEST Analysis
4. Global Asthma Therapeutics Market, By Drug Class, 2026-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Corticosteroids
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Beta2-Agonists (Long-Acting and Short-Acting)
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Leukotriene Inhibitors
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Long-Acting Muscarinic Antagonists (LAMA)
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Interleukin Antagonists
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Anti-Immunoglobulin E (IgE) Agents
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Combination Products
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Others
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
5. Global Asthma Therapeutics Market, By Route of Administration, 2026-2033, (USD Bn)
- Oral
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Inhalation
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Injection
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
6. Global Asthma Therapeutics Market, By Distribution Chanel, 2026-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Retail Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Online Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
7. Global Asthma Therapeutics Market, By Region, 2026-2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- North America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast By Country, 2026-2033, (USD Bn)
- US.
- Canada
- Europe
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast By Country, 2026-2033, (USD Bn)
- UK.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast By Country, 2026-2033, (USD Bn)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast By Country, 2026-2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast By Country, 2026-2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
- Middle East
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast By Country, 2026-2033, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
8. Competitive Landscape
- Heat Map Analysis
- Company Profiles
- GlaxoSmithKline Plc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Philips Healthcare
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- AstraZeneca Plc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Boehringer Ingelheim GmbH
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Sanofi- Aventis SA
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- CareFusion Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Sunovion Pharmaceutical Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Merck & Co. Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Roche Diagnostics
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Analyst Views
- GlaxoSmithKline Plc.
9. Section
- References
- Research Methodology
- About us and Sales Contact
샘플 요청 목록